* "Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer", Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth H., Helm W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross. R, Kabbinavar F., The New England Journal of Medicine, 2004